Literature DB >> 20407811

Molecular basis of autosomal recessive chronic granulomatous disease in iran.

Shahram Teimourian1, Martin de Boer, Dirk Roos.   

Abstract

INTRODUCTION: Chronic granulomatous disease (CGD) is a rare inherited condition resulting from mutations in the genes that encode the proteins of the NADPH oxidase enzyme in phagocytes, rendering these cells incapable of killing invading pathogens.
MATERIALS AND METHODS: Patients subtypes are determined by neutrophil functional assays and immunoblotting. Although defects in the X-chromosome-linked gp91-phox component account for the majority of CGD patients in the world, in Iran, there are many CGD patients suffering from the autosomal recessive forms of the disease. Most of these patients show impairment in the synthesis of the 47-kDa cytosolic component p47-phox of the oxidase. The second causative factor of autosomal recessive CGD is deficiency of the 22-kDa component (p22-phox) of the oxidase. Another rare form of the disease is due to mutations in the NCF2 gene encoding the 67-kDa component (p67-phox) of the oxidase.
RESULTS: Mutation analysis showed a novel homozygous splice site mutation, c.intron4+1G>T, in CYBA. A novel mutation in NCF2: a gross homozygous deletion of exon 1 and 2, causing p.Met1_Lys58 deletion in p67-phox. We also found a previously published homozygous nonsense mutation, c.196C>T, causing p.Arg66X.33 in p67-phox. DISCUSSION: Our data show that CGD in Iran is predominantly due to mutations in p47-phox, while the number of mutations in p22-phox is roughly equal to that in gp91-phox. These data indicate that the genetics of CGD are ethnically variable, and this should be considered in approaching families with CGD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20407811     DOI: 10.1007/s10875-010-9421-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  21 in total

1.  A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease.

Authors:  A Görlach; P L Lee; J Roesler; P J Hopkins; B Christensen; E D Green; S J Chanock; J T Curnutte
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase.

Authors:  Dirk Roos; Martin de Boer; M Yavuz Köker; Jan Dekker; Vinita Singh-Gupta; Anders Ahlin; Jan Palmblad; Ozden Sanal; Magdalena Kurenko-Deptuch; Stephen Jolles; Baruch Wolach
Journal:  Hum Mutat       Date:  2006-12       Impact factor: 4.878

Review 3.  Chronic granulomatous disease and other disorders of phagocyte function.

Authors:  Mary C Dinauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

4.  Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia.

Authors:  R El Kares; M R Barbouche; H Elloumi-Zghal; M Bejaoui; J Chemli; F Mellouli; N Tebib; M S Abdelmoula; S Boukthir; Z Fitouri; S M'Rad; K Bouslama; H Touiri; S Abdelhak; M K Dellagi
Journal:  J Hum Genet       Date:  2006-08-26       Impact factor: 3.172

5.  Genotype-dependent variability in flow cytometric evaluation of reduced nicotinamide adenine dinucleotide phosphate oxidase function in patients with chronic granulomatous disease.

Authors:  S J Vowells; T A Fleisher; S Sekhsaria; D W Alling; T E Maguire; H L Malech
Journal:  J Pediatr       Date:  1996-01       Impact factor: 4.406

6.  Mutations of chronic granulomatous disease in Turkish families.

Authors:  M Y Köker; O Sanal; M De Boer; I Tezcan; A Metin; F Ersoy; D Roos
Journal:  Eur J Clin Invest       Date:  2007-07       Impact factor: 4.686

7.  Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease.

Authors:  M Y Köker; K van Leeuwen; M de Boer; F Celmeli; A Metin; T T Ozgür; I Tezcan; O Sanal; D Roos
Journal:  Eur J Clin Invest       Date:  2009-04       Impact factor: 4.686

8.  Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients.

Authors:  Baruch Wolach; Ronit Gavrieli; Martin de Boer; Giora Gottesman; Josef Ben-Ari; Menachem Rottem; Yechiel Schlesinger; Galia Grisaru-Soen; Amos Etzioni; Dirk Roos
Journal:  Clin Immunol       Date:  2008-08-16       Impact factor: 3.969

9.  Characterization of six novel mutations in CYBA: the gene causing autosomal recessive chronic granulomatous disease.

Authors:  Shahram Teimourian; Elham Zomorodian; Mohsen Badalzadeh; Alireza Pouya; Caroline Kannengiesser; Davood Mansouri; Taher Cheraghi; Nima Parvaneh
Journal:  Br J Haematol       Date:  2008-04-18       Impact factor: 6.998

10.  Chronic granulomatous disease: the European experience.

Authors:  J Merlijn van den Berg; Elsbeth van Koppen; Anders Ahlin; Bernd H Belohradsky; Ewa Bernatowska; Lucien Corbeel; Teresa Español; Alain Fischer; Magdalena Kurenko-Deptuch; Richard Mouy; Theoni Petropoulou; Joachim Roesler; Reinhard Seger; Marie-José Stasia; Niels H Valerius; Ron S Weening; Baruch Wolach; Dirk Roos; Taco W Kuijpers
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

View more
  7 in total

1.  Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.

Authors:  Manasi Kulkarni; Gouri Hule; Martin de Boer; Karin van Leeuwen; Priyanka Kambli; Jahnavi Aluri; Maya Gupta; Aparna Dalvi; Snehal Mhatre; Prasad Taur; Mukesh Desai; Manisha Madkaikar
Journal:  J Clin Immunol       Date:  2018-11-23       Impact factor: 8.317

2.  Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations.

Authors:  Xana Kim-Howard; Celi Sun; Julio E Molineros; Amit K Maiti; Hema Chandru; Adam Adler; Graham B Wiley; Kenneth M Kaufman; Leah Kottyan; Joel M Guthridge; Astrid Rasmussen; Jennifer Kelly; Elena Sánchez; Prithvi Raj; Quan-Zhen Li; So-Young Bang; Hye-Soon Lee; Tae-Hwan Kim; Young Mo Kang; Chang-Hee Suh; Won Tae Chung; Yong-Beom Park; Jung-Yoon Choe; Seung Cheol Shim; Shin-Seok Lee; Bok-Ghee Han; Nancy J Olsen; David R Karp; Kathy Moser; Bernardo A Pons-Estel; Edward K Wakeland; Judith A James; John B Harley; Sang-Cheol Bae; Patrick M Gaffney; Marta Alarcón-Riquelme; Loren L Looger; Swapan K Nath
Journal:  Hum Mol Genet       Date:  2013-10-26       Impact factor: 6.150

3.  Fourth Update on the Iranian National Registry of Primary Immunodeficiencies: Integration of Molecular Diagnosis.

Authors:  Hassan Abolhassani; Fatemeh Kiaee; Marzieh Tavakol; Zahra Chavoshzadeh; Seyed Alireza Mahdaviani; Tooba Momen; Reza Yazdani; Gholamreza Azizi; Sima Habibi; Mohammad Gharagozlou; Masoud Movahedi; Amir Ali Hamidieh; Nasrin Behniafard; Mohammamd Nabavi; Mohammad Hassan Bemanian; Saba Arshi; Rasol Molatefi; Roya Sherkat; Afshin Shirkani; Reza Amin; Soheila Aleyasin; Reza Faridhosseini; Farahzad Jabbari-Azad; Iraj Mohammadzadeh; Javad Ghaffari; Alireza Shafiei; Arash Kalantari; Mahboubeh Mansouri; Mehrnaz Mesdaghi; Delara Babaie; Hamid Ahanchian; Maryam Khoshkhui; Habib Soheili; Mohammad Hossein Eslamian; Taher Cheraghi; Abbas Dabbaghzadeh; Mahmoud Tavassoli; Rasoul Nasiri Kalmarzi; Seyed Hamidreza Mortazavi; Sara Kashef; Hossein Esmaeilzadeh; Javad Tafaroji; Abbas Khalili; Fariborz Zandieh; Mahnaz Sadeghi-Shabestari; Sepideh Darougar; Fatemeh Behmanesh; Hedayat Akbari; Mohammadreza Zandkarimi; Farhad Abolnezhadian; Abbas Fayezi; Mojgan Moghtaderi; Akefeh Ahmadiafshar; Behzad Shakerian; Vahid Sajedi; Behrang Taghvaei; Mojgan Safari; Marzieh Heidarzadeh; Babak Ghalebaghi; Seyed Mohammad Fathi; Behzad Darabi; Saeed Bazregari; Nasrin Bazargan; Morteza Fallahpour; Alireza Khayatzadeh; Naser Javahertrash; Bahram Bashardoust; Mohammadali Zamani; Azam Mohsenzadeh; Sarehsadat Ebrahimi; Samin Sharafian; Ahmad Vosughimotlagh; Mitra Tafakoridelbari; Maziar Rahimi; Parisa Ashournia; Anahita Razaghian; Arezou Rezaei; Setareh Mamishi; Nima Parvaneh; Nima Rezaei; Lennart Hammarström; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2018-10-09       Impact factor: 8.317

Review 4.  An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets.

Authors:  Shahram Nemati; Shahram Teimourian
Journal:  Middle East J Dig Dis       Date:  2017-04

5.  The co-occurrence of rare non-ocular phenotypes in patients with inherited retinal degenerations.

Authors:  Miriam Ehrenberg; Shirel Weiss; Naama Orenstein; Nitza Goldenberg-Cohen; Tamar Ben-Yosef
Journal:  Mol Vis       Date:  2019-11-14       Impact factor: 2.367

6.  Variable Presentation of the CYBB Mutation in One Family, Approach to Management, and a Review of the Literature.

Authors:  Tatyana Gavrilova; Ari Zelig; Diana H Lee
Journal:  Case Rep Med       Date:  2020-02-06

Review 7.  A novel variant in the neutrophil cytosolic factor 2 (NCF2) gene results in severe disseminated BCG infectious disease: A clinical report and literature review.

Authors:  Suzan A AlKhater; Caroline Deswarte; Jean-Laurent Casanova; Jacinta Bustamante
Journal:  Mol Genet Genomic Med       Date:  2020-04-12       Impact factor: 2.183

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.